Sort
261,768 grants matching “gene therapy”
Non-cytotoxic augmentation of fetal hemoglobin and bone marrow reserves
$998,309Yogen Saunthararajah · University Of Michigan At Ann Arbor · P01 · FY2019 · HL
Gene Therapy for Urea Cycle Disorders
$998,305James M Wilson · University Of Pennsylvania · P01 · FY2010 · HD
Relating Molecular Subgroups of Endometriosis-Associated Ovarian Cancers to Survival and Risk
$998,304Ellen L. Goode · Mayo Clinic Rochester · R01 · FY2022 · CA
Inflammation, Viral Replication, and Atherosclerosis in Treated HIV Infection
$998,266Priscilla Y. Hsue · University Of California, San Francisco · R01 · FY2010 · HL
Novel mechanisms of NSAID action in Alzheimer disease
$998,120University Of California San Diego · P01 · FY2002 · AG
Protecting Pancreatic Islet Grafts from Rejection
$998,068Uwe D. Staerz · Isogenis, Inc. · R44 · FY2008 · DK
A Haplotype Map for Multiple Sclerosis
$997,968Stephen L Hauser · University Of California, San Francisco · R01 · FY2013 · NS
Development of Broad Spectrum Host Oriented Therapeutic Antibodies against Influe
$997,899Wu-Bo Li · Functional Genetics, Inc. · R44 · FY2012 · AI
Novel small-molecule therapies for CF
$997,891Alan S Verkman · University Of California, San Francisco · P30 · FY2007 · DK
Role of Viral Reservoirs in the Pathogenesis of HIV Disease
$997,850Anthony S. Fauci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Mechanisms of neocortical and sensory hyperexcitability in Fragile X Syndrome
$997,830Kimberly M Huber · Ut Southwestern Medical Center · U54 · FY2019 · HD
Automated Systems for Detection and Molecular Characterization of Circulating Tum
$997,818Yuling Luo · Advanced Cell Diagnostics, Inc. · R44 · FY2010 · CA
The von Hippel-Lindau Tumor Suppressor Gene and Kidney Cancer: Insights into Oxygen Sensing and Treating Cancers Caused by Undruggable Mutations
$997,800William G Kaelin · Dana-Farber Cancer Inst · R35 · FY2025 · CA
The von Hippel-Lindau Tumor Suppressor Gene and Kidney Cancer: Insights into Oxygen Sensing and Treating Cancers Caused by Undruggable Mutations
$997,800William G Kaelin · Dana-Farber Cancer Inst · R35 · FY2023 · CA
Novel Vaginal Microbicides Based On Stable AAV-Neutralizing Antibody Gene Transfe
$997,779Wayne A. Marasco · Dana-Farber Cancer Inst · R33 · FY2010 · AI
Pilot trial of dronabinol adjunctive treatment of agitation in Alzheimer's disease (AD)
$997,731Paul B Rosenberg · Johns Hopkins University · R01 · FY2020 · AG
Medical Retina Fellowship
$997,688Catherine Cukras · National Eye Institute · ZIE · FY2022 · EY
Rapid, Multiplexed Biosensor for Non-Invasive Detection of Gene Mutations and Personalization of Therapy in Non-Small Cell Lung Cancer
$997,685Avni A Argun · Giner, Inc. · R44 · FY2023 · CA
Preclinical pharmacology, toxicology, biodistribution and dosimetry, and radionuclide production CMC validation for Pb-212 receptor targeted alpha-particle therapy for neuroendocrine tumors.
$997,658Michael King Schultz · Viewpoint Molecular Targeting, Inc. · R44 · FY2020 · CA
Characterization of CAR-directed T-cells to suppress HIV-1 in vivo
$997,645Scott G Kitchen · University Of California Los Angeles · U19 · FY2016 · AI
Development of TP-317 in Ulcerative Colitis
$997,635John Parkinson · Thetis Pharmaceuticals, Llc · R44 · FY2023 · DK
Antibody-Biocide Fusions to Control Cryptosporidium
$997,510Michael Imboden · Iogenetics, Llc · R44 · FY2009 · AI
Discovery, Regulation and Function of the PI 3-Kinase and AKT Pathway in Cancer
$997,501Alex Toker · Beth Israel Deaconess Medical Center · R35 · FY2024 · CA
Deciphering the physiological role and interplay between ubiquitination and phosphorylation pathways to guide targeted cancer therapies
$997,500Wenyi Wei · Beth Israel Deaconess Medical Center · R35 · FY2024 · CA
Precision microRNA medicine in cancer
$997,500Frank J. Slack · Beth Israel Deaconess Medical Center · R35 · FY2024 · CA